{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:48:13Z","timestamp":1793450893369,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:00:00Z","timestamp":1606262400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:00:00Z","timestamp":1606262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fondo de Investigaci\u00f3n en Salud","award":["FIS\/IMSS\/PROT\/PRIO\/14\/033 and FIS\/IMSS\/PROT\/EMER18\/1844"],"award-info":[{"award-number":["FIS\/IMSS\/PROT\/PRIO\/14\/033 and FIS\/IMSS\/PROT\/EMER18\/1844"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Human papillomavirus infection is an important factor associated with cervical cancer (CC) development. The prevalence and genotype distribution vary greatly worldwide. Examining local epidemiological data constitutes an important step towards the development of vaccines to prevent CC. In this work, we studied the prevalence of HPV genotypes in women from Western Mexico with the COBAS 4800 and\/or Linear Array Genotyping Test (LA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The samples analysed in this study represent a population from Western Mexico, which includes six different states. Our approach was first to test for HPV in cervical samples from women who attended their health clinic for routine gynaecological studies (open-population,<jats:italic>n<\/jats:italic>\u2009=\u20093000) by utilizing COBAS 4800. Afterwards, 300 of the HPV-positive samples were randomly selected to be genotyped with LA; finally, we genotyped samples from women with cervical intraepithelial neoplasia grade 1 (CIN 1,<jats:italic>n<\/jats:italic>\u2009=\u200971) and CC (<jats:italic>n<\/jats:italic>\u2009=\u200996) with LA. Sociodemographic data of the diverse groups were also compared.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The overall HPV prevalence among the open-population of women as determined by COBAS 4800 was 12.1% (<jats:italic>n<\/jats:italic>\u2009=\u2009364\/3000). Among the HPV-positive samples, single infections (SI) with HPV16 were detected in 12.4% (<jats:italic>n<\/jats:italic>\u2009=\u200945\/364), SI with HPV18 were detected in 1.4%, and infection with at least one of the genotypes included in the high-risk HPV pool was detected in 74.5% of the cases. LA analysis of the samples showed that in addition to HPV genotypes 16 and 18, there was a high prevalence of HPV genotypes 59, 66, 52, 51, 39 and 56 in women from Western Mexico. With respect to the sociodemographic data, we found statistically significant differences in the number of pregnancies, the use of hormonal contraceptives and tobacco intake.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our data indicate that there is a high prevalence of HPV genotypes which are not covered by the vaccines currently available in Mexico; therefore, it is necessary to include HPVs 59, 66, 51, 39 and 56 in the design of future vaccines to reduce the risk of CC development. It is also essential to emphasize that the use of hormonal contraceptives and tobacco smoking are risk factors for CC development in addition to the presence of HPV.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12879-020-05627-x","type":"journal-article","created":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T13:03:07Z","timestamp":1606309387000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["High frequency of HPV genotypes 59, 66, 52, 51, 39 and 56 in women from Western Mexico"],"prefix":"10.1186","volume":"20","author":[{"given":"Andrea","family":"Molina-Pineda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Guadalupe","family":"L\u00f3pez-Cardona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Patricia","family":"Lim\u00f3n-Toledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Cant\u00f3n-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Guadalupe","family":"Mart\u00ednez-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holanda Vanesa","family":"Ramos-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Guadalupe","family":"Flores-Miramontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"de la Mata-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis F.","family":"Jave-Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9288-4824","authenticated-orcid":false,"given":"Adriana","family":"Aguilar-Lemarroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,25]]},"reference":[{"issue":"00","key":"5627_CR1","first-page":"1","volume":"00","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I. Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;00(00):1\u201331.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"5627_CR2","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrc798","volume":"2","author":"H Zur Hausen","year":"2002","unstructured":"Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Natl Rev. 2002;2(5):342\u201350.","journal-title":"Natl Rev"},{"key":"5627_CR3","first-page":"244","volume-title":"The causal relation between human papillomavirus and cervical cancer","author":"FX Bosch","year":"2002","unstructured":"Bosch FX, Lorincz A, Mu\u00f1oz N, Meijer CJLM, Shah KV. The causal relation between human papillomavirus and cervical cancer; 2002. p. 244\u201365."},{"key":"5627_CR4","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1056\/NEJM199210293271804","volume":"327","author":"LA Koutsky","year":"1992","unstructured":"Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med. 1992;327:1272\u20138.","journal-title":"N Engl J Med"},{"key":"5627_CR5","unstructured":"HPV Center. International human papillomavirus reference Center. Davit Bzhalava, Karolinska Instituet. Available from: http:\/\/www.nordicehealth.se\/hpvcenter\/reference_clones\/: [Accessed 2020 Feb 7]."},{"issue":"11","key":"5627_CR6","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/jnci\/87.11.796","volume":"87","author":"F Bosch","year":"1995","unstructured":"Bosch F, Manos M, Mu\u00f1oz N, Sherman M, Jansen A, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) study group. J Natl Cancer Inst. 1995;87(11):796\u2013802.","journal-title":"J Natl Cancer Inst"},{"key":"5627_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/sj.bjc.6600688","volume":"88","author":"G Clifford","year":"2003","unstructured":"Clifford G, Smith J, Franceschi S, Plummer M. Human papillomavirus types in invasive cervical cancer worldwide : a meta-analysis. Br J Cancer. 2003;88:63\u201373.","journal-title":"Br J Cancer"},{"issue":"4","key":"5627_CR8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","volume":"10","author":"V Bouvard","year":"2009","unstructured":"Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, et al. A review of human carcinogens--part B: biological agents. Lancet Oncol. 2009;10(4):321\u20132Available from:. https:\/\/doi.org\/10.1016\/S1470-2045(09)70096-8.","journal-title":"Lancet Oncol"},{"key":"5627_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1470-2045(09)70096-8","volume":"100B","author":"IARC Working Group","year":"2012","unstructured":"IARC Working Group. Biological agents. Part B. Areview of human carcinogens. IARC Monographs. 2012;100B:1\u2013441. https:\/\/doi.org\/10.1016\/S1470-2045(09)70096-8.","journal-title":"IARC Monographs"},{"issue":"4","key":"5627_CR10","first-page":"57","volume":"7","author":"HW Haverkos","year":"2005","unstructured":"Haverkos HW. Multifactorial etiology of cervical cancer: a hypothesis. Medscape Gen Med. 2005;7(4):57.","journal-title":"Medscape Gen Med"},{"issue":"11","key":"5627_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S1470-2045(10)70230-8","volume":"11","author":"S De Sanjose","year":"2010","unstructured":"De Sanjose S, Quint WGV, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer : a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11(11):7\u201311.","journal-title":"Lancet Oncol"},{"issue":"4","key":"5627_CR12","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/ijc.25396","volume":"128","author":"N Li","year":"2011","unstructured":"Li N, Franceschi S, Howell-jones R, Snijders PJF, Clifford GM. Human paillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer. 2011;128(4):927\u201335.","journal-title":"Int J Cancer"},{"issue":"5","key":"5627_CR13","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/jmv.24099","volume":"87","author":"A Aguilar-Lemarroy","year":"2015","unstructured":"Aguilar-Lemarroy A, Vallejo-Ruiz V, Cort\u00e9s-Guti\u00e9rrez EI, Ramos-Gonzalez NP, Ortega-Cervantes L, Salgado-Bernabe ME, et al. Human papillomavirus infections in Mexican women with Normal cytology , precancerous lesions , and cervical cancer : type-specific prevalence and HPV Coinfections. J Med Virol. 2015;87(5):871\u201384.","journal-title":"J Med Virol"},{"issue":"5","key":"5627_CR14","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.bjid.2014.01.010","volume":"18","author":"R Iwasaki","year":"2014","unstructured":"Iwasaki R, Galvez-Philpott F, Arias-Stella JJ, Arias-Stella J. Original article prevalence of high-risk human papillomavirus by cobas 4800 HPV test in urban Peru. Braz J Infect Dis. 2014;18(5):469\u201372.","journal-title":"Braz J Infect Dis"},{"issue":"6","key":"5627_CR15","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1128\/JCM.00104-06","volume":"44","author":"F Coutl\u00e9e","year":"2006","unstructured":"Coutl\u00e9e F, Rouleau D, Petignat P, Ghattas G, Kornegay JR, Schlag P, et al. Enhanced detection and typing of human papillomavirus ( HPV ) DNA in Anogenital samples with PGMY primers and the linear Array HPV genotyping test. J Clin Microbiol. 2006;44(6):1998\u20132006.","journal-title":"J Clin Microbiol"},{"issue":"6","key":"5627_CR16","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/ijc.10868","volume":"103","author":"EM De Villiers","year":"2003","unstructured":"De Villiers EM. Relationship between steroid hormone contraceptives and HPV, cervical intraepithelial neoplasia and cervical carcinoma. Int J Cancer. 2003;103(6):705\u20138.","journal-title":"Int J Cancer"},{"issue":"5","key":"5627_CR17","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/sj.bjc.6605224","volume":"101","author":"S Franceschi","year":"2009","unstructured":"Franceschi S, Plummer M, Clifford G, De Sanjose S, Bosch X, Herrero R, et al. Differences in the risk of cervical cancer and human papillomavirus infection by education level. Br J Cancer. 2009;101(5):865\u201370.","journal-title":"Br J Cancer"},{"issue":"9","key":"5627_CR18","doi-asserted-by":"publisher","first-page":"3893","DOI":"10.7314\/APJCP.2015.16.9.3893","volume":"16","author":"Z-C Liu","year":"2015","unstructured":"Liu Z-C, Liu W-D, Liu Y-H, Ye X-H, Chen S-D. Multiple sexual partners as a potential independent risk factor for cervical cancer: a meta-analysis of epidemiological studies. Asian Pac J Cancer Prev. 2015;16(9):3893\u2013900.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"5627_CR19","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/bjc.2012.513","volume":"108","author":"KE Jensen","year":"2013","unstructured":"Jensen KE, Schmiedel S, Norrild B, Frederiksen K, Iftner T, Kjaer SK. Parity as a cofactor for high-grade cervical disease among women with persistent human papillomavirus infection: a 13-year follow-up. Br J Cancer. 2013;108(1):234\u20139Available from:. https:\/\/doi.org\/10.1038\/bjc.2012.513.","journal-title":"Br J Cancer"},{"issue":"3","key":"5627_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.osfp.2011.09.003","volume":"4","author":"BA Cox","year":"2012","unstructured":"Cox BA, Crow WT, Johnson L. Current nutritional considerations for prevention of cervical cancer. Osteopath Fam Physician. 2012;4(3):81\u20134Available from:. https:\/\/doi.org\/10.1016\/j.osfp.2011.09.003.","journal-title":"Osteopath Fam Physician"},{"issue":"3","key":"5627_CR21","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.maturitas.2013.11.010","volume":"77","author":"R Baena Ruiz","year":"2014","unstructured":"Baena Ruiz R, Salinas HP. Diet and cancer: risk factors and epidemiological evidence. Maturitas. 2014;77(3):202\u20138Available from:. https:\/\/doi.org\/10.1016\/j.maturitas.2013.11.010.","journal-title":"Maturitas."},{"issue":"10","key":"5627_CR22","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1158\/1055-9965.1574.13.10","volume":"13","author":"TS Shields","year":"2004","unstructured":"Shields TS, Brinton LA, Burk RD, Wang SS, Weinstein SJ, Ziegler RG, et al. A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus. Cancer Epidemiol Biomarkers Prev. 2004;13(10):1574\u201382.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"5627_CR23","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/ijc.21953","volume":"119","author":"T Rajkumar","year":"2006","unstructured":"Rajkumar T, Cuzick J, Appleby P, Barnabas R, Beral V, Berrington De Gonz\u00e1lez A, et al. Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies. Int J Cancer. 2006;119(5):1108\u201324.","journal-title":"Int J Cancer"},{"issue":"18","key":"5627_CR24","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1093\/jnci\/94.18.1406","volume":"94","author":"PE Castle","year":"2002","unstructured":"Castle PE, Wacholder S, Lorincz AT, Scott DR, Sherman ME, Glass AG, et al. A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. J Natl Cancer Inst. 2002;94(18):1406\u201314.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"5627_CR25","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/ijc.21279","volume":"117","author":"PE Castle","year":"2005","unstructured":"Castle PE, Walker JL, Schiffman M, Wheeler CM. Hormonal contraceptive use, pregnancy and parity, and the risk of cervical intraepithelial neoplasia 3 among oncogenic HPV DNA-positive women with equivocal or mildly abnormal cytology. Int J Cancer. 2005;117(6):1007\u201312.","journal-title":"Int J Cancer"},{"key":"5627_CR26","doi-asserted-by":"publisher","unstructured":"Moreno V, Bosch FX, Mu\u00f1oz N, Meijer CJLM, Shah KV, Walboomers JMM, et al. K -- effect of oral contraceptives on risk of cervical can. Lancet. 2002;359(9312):1085\u201392. https:\/\/doi.org\/10.1016\/2Fs0140-6736(2802)2908150-3.","DOI":"10.1016\/2Fs0140-6736(2802)2908150-3"},{"issue":"9599","key":"5627_CR27","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/S0140-6736(07)61684-5","volume":"370","author":"Collaboration I, Studies E, Cancer C","year":"2007","unstructured":"Collaboration I, Studies E, Cancer C. Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16 573 women with cervical cancer and 35 509 women without cervical cancer from 24 epidemiological studies. Lancet. 2007;370(9599):1609\u201321.","journal-title":"Lancet."},{"issue":"2","key":"5627_CR28","first-page":"319","volume":"19","author":"AD Shrestha","year":"2018","unstructured":"Shrestha AD, Neupane D, Vedsted P, Kallestrup P. Cervical cancer prevalence, incidence and mortality in low and middle income countries: a systematic review. Asian Pac J Cancer Prev. 2018;19(2):319\u201324.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"4","key":"5627_CR29","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/ijc.22357","volume":"120","author":"A Berrington De Gonz\u00e1lez","year":"2007","unstructured":"Berrington De Gonz\u00e1lez A, Green J. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer. 2007;120(4):885\u201391.","journal-title":"Int J Cancer"},{"issue":"2","key":"5627_CR30","doi-asserted-by":"publisher","first-page":"197","DOI":"10.21149\/spm.v58i2.7789","volume":"58","author":"L Torres-Ibarra","year":"2016","unstructured":"Torres-Ibarra L, Lazcano-Ponce E, Franco EL, Cuzick J, Hern\u00e1ndez-\u00c1vila M, Lorincz A, et al. Triage strategies in cervical cancer detection in Mexico : methods of the FRIDA study. Salud Publica Mex. 2016;58(2):197\u2013210.","journal-title":"Salud Publica Mex"},{"key":"5627_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1155\/2012\/384758","volume":"2012","author":"MG L\u00f3pez-Rivera","year":"2012","unstructured":"L\u00f3pez-Rivera MG, Medel-Flores M-O, Villalba-Magdaleno J-D, S\u00e1nchez-Monroy V. Prevalence of human papillomavirus in women from Mexico City. Infect Dis Obstet Gynecol. 2012;2012:15\u20138.","journal-title":"Infect Dis Obstet Gynecol"},{"issue":"7","key":"5627_CR32","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.vaccine.2012.09.085","volume":"31","author":"GS Ogilvie","year":"2013","unstructured":"Ogilvie GS, Cook DA, Taylor DL, Rank C, Kan L, Yu A, et al. Population-based evaluation of type-specific HPV prevalence among women in British Columbia, Canada. Vaccine. 2013;31(7):1129\u201333.","journal-title":"Vaccine"},{"key":"5627_CR33","first-page":"4","volume-title":"Prevalence of human papillomavirus infection among Iranian women using COBAS HPV DNA testing","author":"F Jamdar","year":"2018","unstructured":"Jamdar F, Farzaneh F, Navidpour F, Younesi S, Balvayeh P. Prevalence of human papillomavirus infection among Iranian women using COBAS HPV DNA testing; 2018. p. 4\u20138."},{"issue":"3","key":"5627_CR34","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.vaccine.2018.11.075","volume":"37","author":"JM Brotherton","year":"2019","unstructured":"Brotherton JM, Hawkes D, Sultana F, Malloy MJ, Machalek DA, Smith MA, et al. Age-specific HPV prevalence among 116 , 052 women in Australia\u2019s renewed cervical screening program: a new tool for monitoring vaccine impact. Vaccine. 2019;37(3):412\u20136.","journal-title":"Vaccine."},{"key":"5627_CR35","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1111\/cas.13608","volume":"109","author":"S Aoyama-Kikawa","year":"2018","unstructured":"Aoyama-Kikawa S, Fujita H, Hanley SJB. Comparison of human papillomavirus genotyping and cytology triage , COMPACT study : design , methods and baseline results in 14 642 women. Cancer Sci. 2018;109:2003\u201312.","journal-title":"Cancer Sci"},{"issue":"15","key":"5627_CR36","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1001\/jama.1994.03510390051029","volume":"271","author":"TM Becker","year":"1994","unstructured":"Becker TM, Wheeler CM, Mcgough NS, Parmenter CA, Jordan SW, Stidley CA, et al. Sexually transmitted diseases and other risk factors for cervical dysplasia among southwestern Hispanic and non-Hispanic White women. JAMA. 1994;271(15):1181\u20138.","journal-title":"JAMA"},{"key":"5627_CR37","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ijc.30716","volume":"141","author":"C de Martel","year":"2017","unstructured":"de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141:664\u201370.","journal-title":"Int J Cancer"},{"key":"5627_CR38","first-page":"202","volume":"29","author":"G-L del MR","year":"2004","unstructured":"del MR G-L, Rosado-Lopez I, Valdez-Gonz\u00e1lez N, Puerto-Sol\u00eds M. High prevalence of human papillomavirus type 58 in Mexican colposcopy patients. J Clin Virol. 2004;29:202\u20135.","journal-title":"J Clin Virol"},{"issue":"3","key":"5627_CR39","first-page":"1","volume":"16","author":"R L\u00f3pez-Revilla","year":"2008","unstructured":"L\u00f3pez-Revilla R, Mart\u00ednez-Contreras LA, S\u00e1nchez-Garza M. Prevalence of high-risk human papillomavirus types in Mexican women with cervical intraepithelial neoplasia and invasive carcinoma. Infect Agent Cancer. 2008;16(3):1\u201313.","journal-title":"Infect Agent Cancer"},{"issue":"161","key":"5627_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12985-015-0391-4","volume":"12","author":"MG Flores-Miramontes","year":"2015","unstructured":"Flores-Miramontes MG, Torres-Reyes LA, Alvarado-Ru\u00edz L, Romero-Mart\u00ednez SA, Ram\u00edrez-Rodr\u00edguez V, Balderas-Pe\u00f1a LMA, et al. Human papillomavirus genotyping by linear Array and next-generation sequencing in cervical samples from Western Mexico. Virol J. 2015;12(161):1\u201311Available from:. https:\/\/doi.org\/10.1186\/s12985-015-0391-4.","journal-title":"Virol J"},{"issue":"11","key":"5627_CR41","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","volume":"11","author":"S de Sanjose","year":"2010","unstructured":"de Sanjose S, Quint WGV, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11(11):1048\u201356.","journal-title":"Lancet Oncol"},{"key":"5627_CR42","doi-asserted-by":"publisher","first-page":"F12","DOI":"10.1016\/j.vaccine.2012.07.055","volume":"30","author":"D Forman","year":"2012","unstructured":"Forman D, De Martel C, Lacey CJ, Soerjomataram I, Lortet-tieulent J, Bruni L, et al. Global burden of human papillomavirus and related diseases. Vaccine. 2012;30:F12\u201323Available from:. https:\/\/doi.org\/10.1016\/j.vaccine.2012.07.055.","journal-title":"Vaccine."},{"key":"5627_CR43","first-page":"2417","volume":"19","author":"E Navarro-Vidal","year":"2018","unstructured":"Navarro-Vidal E, Hernandez-Rosas F, Rey M, Flores-Peredo L. Prevalence of human papillomavirus genotypes in women from Cozumel. Mexico. 2018;19:2417\u201322.","journal-title":"Mexico."},{"key":"5627_CR44","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/ijgo.12009","volume":"136","author":"OR Fajardo-Ram\u00edrez","year":"2017","unstructured":"Fajardo-Ram\u00edrez OR, Barboza-Cerda MC, Ortiz-L\u00f3pez R, Rojas-Mart\u00ednez A, Garza-rodr\u00edguez ML, Sep\u00falveda-Flores A, et al. Prevalence and 3- \u00adyear persistence of human papillomavirus serotypes in asymptomatic patients in northern Mexico. Int J Gynecol Obstet. 2017;136:40\u20136.","journal-title":"Int J Gynecol Obstet"},{"key":"5627_CR45","first-page":"262","volume":"69","author":"I J\u00e1come-Galarza","year":"2017","unstructured":"J\u00e1come-Galarza I, Ito-Nakashimada MA, Figueroa-Aguilar G, Garc\u00eda-Latorre E, Salazar MI, L\u00f3pez-Ordu\u00f1a E, et al. Prevalence of human papillomavirus in women from the state of Michoacan , Mexico, showed high frequency of unusual virus genotypes. Rev Investig Cl\u00ednica. 2017;69:262\u20139.","journal-title":"Rev Investig Cl\u00ednica"},{"issue":"23","key":"5627_CR46","doi-asserted-by":"publisher","first-page":"10061","DOI":"10.7314\/APJCP.2014.15.23.10061","volume":"15","author":"M Salcedo","year":"2014","unstructured":"Salcedo M, Pina-Sanchez P, Vallejo-Ruiz V, Aguilar-Lemarroy A, Cortes-Gutierrez EI, Montoya-fuentes H, et al. Human papillomavirus genotypes among females in Mexico : a study from the Mexican Institute for Social Security. Asian Pac J Cancer Prev. 2014;15(23):10061\u20136.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"6","key":"5627_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0218762","volume":"14","author":"A Krings","year":"2019","unstructured":"Krings A, Dunyo P, Pesic A, Tetteh S, Hansen B, Gedzah I, et al. Characterization of human papillomavirus prevalence and risk factors to guide cervical cancer screening in the north Tongu District, Ghana. PLoS One. 2019;14(6):1\u201319.","journal-title":"PLoS One"},{"issue":"202","key":"5627_CR48","first-page":"7","volume":"8","author":"E Wu","year":"2008","unstructured":"Wu E, Zhang G, Yu X, Ren Y, Fan Y, Kong W, et al. Evaluation of high-risk human papillomaviruses type distribution in cervical cancer in Sichuan province of China. BMC Cancer. 2008;8(202):7\u201313.","journal-title":"BMC Cancer"},{"issue":"160","key":"5627_CR49","first-page":"1","volume":"12","author":"S Wang","year":"2012","unstructured":"Wang S, Wei H, Wang N, Zhang S, Zhang Y, Ruan Q, et al. The prevalence and role of human papillomavirus genotypes in primary cervical screening in the northeast of China. BMC Cancer. 2012;12(160):1\u201310.","journal-title":"BMC Cancer"},{"issue":"3","key":"5627_CR50","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.yexmp.2015.09.008","volume":"99","author":"F Ye","year":"2015","unstructured":"Ye F, Chan N, Feng T, Wu J, Jiang S, Sperling R, et al. High prevalence of HPV59 in cytologically abnormal cervical samples. Exp Mol Pathol. 2015;99(3):611\u20136Available from:. https:\/\/doi.org\/10.1016\/j.yexmp.2015.09.008.","journal-title":"Exp Mol Pathol"},{"issue":"1","key":"5627_CR51","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jcv.2009.03.005","volume":"45","author":"M Dobec","year":"2009","unstructured":"Dobec M, Bannwart F, Kaeppeli F, Cassinotti P. Automation of the linear array HPV genotyping test and its application for routine typing of human papillomaviruses in cervical specimens of women without cytological abnormalities in Switzerland. J Clin Virol. 2009;45(1):23\u20137.","journal-title":"J Clin Virol"},{"issue":"11","key":"5627_CR52","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1007\/s00705-020-04771-8","volume":"165","author":"K Ju\u00e1rez-Gonz\u00e1lez","year":"2020","unstructured":"Ju\u00e1rez-Gonz\u00e1lez K, Paredes-Cervantes V, Gordillo-Rodr\u00edguez S, Gonz\u00e1lez-Guzm\u00e1n S, Moncayo-Valencia X, M\u00e9ndez-Mart\u00ednez R, et al. High prevalence of human papillomavirus type 66 in low-grade cervical lesions of Mexican women. Arch Virol. 2020;165(11):2633\u201340. https:\/\/doi.org\/10.1007\/s00705-020-04771-8.","journal-title":"Arch Virol"},{"issue":"6","key":"5627_CR53","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00430-019-00621-w","volume":"208","author":"M Balanda","year":"2019","unstructured":"Balanda M, Fern\u00e1ndez J, Vergara N, Campano C, Arata L, Mart\u00edn HS, et al. Genetic variability of human papillomavirus type 66 L1 gene among women presenting for cervical cancer screening in Chile. Med Microbiol Immunol. 2019;208(6):757\u201371. https:\/\/doi.org\/10.1007\/s00430-019-00621-w.","journal-title":"Med Microbiol Immunol"},{"issue":"2","key":"5627_CR54","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/ijgo.13126","volume":"149","author":"YP Bule","year":"2020","unstructured":"Bule YP, Silva J, Carrilho C, Campos C, Sousa H, Tavares A, et al. Human papillomavirus prevalence and distribution in self-collected samples from female university students in Maputo. Int J Gynecol Obstet. 2020;149(2):237\u201346.","journal-title":"Int J Gynecol Obstet"},{"issue":"September","key":"5627_CR55","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.pvr.2018.09.001","volume":"6","author":"RA Ouedraogo","year":"2018","unstructured":"Ouedraogo RA, Zohoncon TM, Guigma SP, Ang\u00e8le Traore IM, Ouattara AK, Ouedraogo M, et al. Oncogenic human papillomavirus infection and genotypes characterization among sexually active women in Tenkodogo at Burkina Faso, West Africa. Papillomavirus Res. 2018;6(September):22\u20136. https:\/\/doi.org\/10.1016\/j.pvr.2018.09.001.","journal-title":"Papillomavirus Res"},{"issue":"1","key":"5627_CR56","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ejogrb.2010.02.040","volume":"151","author":"D Wu","year":"2010","unstructured":"Wu D, Cai L, Huang M, Zheng Y, Yu J. European journal of Obstetrics & Gynecology and reproductive biology prevalence of genital human papillomavirus infection and genotypes among women from Fujian province, PR China. Eur J Obstet Gynecol. 2010;151(1):86\u201390. https:\/\/doi.org\/10.1016\/j.ejogrb.2010.02.040.","journal-title":"Eur J Obstet Gynecol"},{"key":"5627_CR57","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.virusres.2009.02.004","volume":"142","author":"A Spinillo","year":"2009","unstructured":"Spinillo A, Dal B, Alberizzi P, Cesari S, Gardella B, Roccio M, et al. Clustering patterns of human papillomavirus genotypes in multiple infections. Virus Res. 2009;142:154\u20139.","journal-title":"Virus Res"},{"issue":"531","key":"5627_CR58","first-page":"1","volume":"17","author":"J Gallegos-Bola\u00f1os","year":"2017","unstructured":"Gallegos-Bola\u00f1os J, Rivera-Dom\u00ednguez JA, Presno-Bernal JM, Cervantes-Villagrana RD. High prevalence of co-infection between human papillomavirus (HPV) 51 and 52 in Mexican population. BMC Cancer. 2017;17(531):1\u20138.","journal-title":"BMC Cancer"},{"key":"5627_CR59","doi-asserted-by":"publisher","first-page":"3257939","DOI":"10.1155\/2019\/3257939","volume":"2019","author":"CK Chan","year":"2019","unstructured":"Chan CK, Aimagambetova G, Ukybassova T, Kongrtay K, Azizan A. Human papillomavirus infection and cervical cancer: epidemiology, screening, and vaccination - review of current perspectives. J Oncol. 2019;2019:3257939.","journal-title":"J Oncol"},{"issue":"2","key":"5627_CR60","first-page":"107","volume":"10","author":"W Tjalma","year":"2018","unstructured":"Tjalma W. HPV negative cervical cancers and primary HPV screening. Facts, views Vis ObGyn. 2018;10(2):107\u201313 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31110650%0Ahttp:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=PMC6516188.","journal-title":"Facts, views Vis ObGyn"},{"issue":"00","key":"5627_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/03630242.2020.1822490","volume":"00","author":"Z Farahmand","year":"2020","unstructured":"Farahmand Z, Soleimanjahi H, Garshasbi M, Hasanzadeh M, Zafari E. Distribution of the most common types of HPV in Iranian women with and without cervical cancer. Women Health. 2020;00(00):1\u201310. https:\/\/doi.org\/10.1080\/03630242.2020.1822490.","journal-title":"Women Health"},{"issue":"4","key":"5627_CR62","first-page":"1","volume":"14","author":"R Guti\u00e9rrez-Campos","year":"2019","unstructured":"Guti\u00e9rrez-Campos R, Malacara-Rosas A, Gutierrez-Santill\u00e1n E, Delgado-Guti\u00e9rrez M, Torres-Orozco R, Garc\u00eda Mart\u00ednez E, et al. Unusual prevalence of high-risk genotypes of human papillomavirus in a group of women with neoplastic lesions and cervical cancer from Central Mexico. PLoS One. 2019;14(4):1\u201313.","journal-title":"PLoS One"},{"issue":"10","key":"5627_CR63","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1002\/ijc.31964","volume":"144","author":"VN Pimenoff","year":"2019","unstructured":"Pimenoff VN, Tous S, Benavente Y, Alemany L, Quint W, Bosch FX, et al. Distinct geographic clustering of oncogenic human papillomaviruses multiple infections in cervical cancers: results from a worldwide cross-sectional study. Int J Cancer. 2019;144(10):2478\u201388.","journal-title":"Int J Cancer"},{"issue":"5","key":"5627_CR64","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1188\/06.CJON.559-560","volume":"10","author":"MR Mclemore","year":"2006","unstructured":"Mclemore MR. Gardasil \u00ae : introducing the new human papillomavirus vaccine. Clin J Oncol Nurs. 2006;10(5):559.","journal-title":"Clin J Oncol Nurs"},{"key":"5627_CR65","doi-asserted-by":"publisher","first-page":"F139","DOI":"10.1016\/j.vaccine.2012.05.039","volume":"305","author":"LE Markowitz","year":"2012","unstructured":"Markowitz LE, Tsu V, Deeks SL, Cubie H, Wang SA, Vicari AS, et al. Human papillomavirus vaccine introduction \u2013 the first five years. Vaccine. 2012;305:F139\u201348Available from:. https:\/\/doi.org\/10.1016\/j.vaccine.2012.05.039.","journal-title":"Vaccine."},{"key":"5627_CR66","first-page":"1","volume-title":"Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease","author":"B Serrano","year":"2012","unstructured":"Serrano B, Alemany L, Tous S, Bruni L, Clifford GM, Weiss T, et al. Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease; 2012. p. 1\u201313."},{"issue":"2","key":"5627_CR67","doi-asserted-by":"publisher","first-page":"46","DOI":"10.7171\/jbt.16-2702-004","volume":"27","author":"NP Ambulos","year":"2016","unstructured":"Ambulos NP, Schumaker LM, Mathias TJ, White R, Troyer J, Wells D, et al. Next-generation sequencing-based HPV genotyping assay validated in formalin-fixed, paraffin-embedded oropharyngeal and cervical cancer specimens. J Biomol Tech. 2016;27(2):46\u201352.","journal-title":"J Biomol Tech"},{"key":"5627_CR68","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3343\/alm.2018.38.2.139","volume":"38","author":"S Payungporn","year":"2018","unstructured":"Payungporn S, Ph D, Poovorawan Y. Comparison of four human papillomavirus genotyping. Ann Lab Med. 2018;38:139\u201346.","journal-title":"Ann Lab Med"},{"key":"5627_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/JCM.01794-18","volume":"57","author":"S Wagner","year":"2019","unstructured":"Wagner S, Roberson D, Boland J, Yeager M, Cullen M, Mirabello L, et al. Development of the TypeSeq assay for detection of 51 human papillomavirus genotypes by next-generation sequencing. J Clin Microbiol. 2019;57:1\u201311.","journal-title":"J Clin Microbiol"},{"issue":"June","key":"5627_CR70","first-page":"1","volume":"10","author":"MG Flores-Miramontes","year":"2020","unstructured":"Flores-Miramontes MG, Olszewski D, Artaza-Irigaray C, Willemsen A, Bravo IG, Vallejo-Ruiz V, et al. Detection of alpha, Beta, gamma, and unclassified human papillomaviruses in cervical cancer samples from Mexican women. Front Cell Infect Microbiol. 2020;10(June):1\u201315.","journal-title":"Front Cell Infect Microbiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05627-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-020-05627-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05627-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T19:35:41Z","timestamp":1669750541000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05627-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,25]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5627"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05627-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,25]]},"assertion":[{"value":"31 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Before the samples were taken, participants provided written informed consent to participate in the study. Ethical approval of this study was obtained from the Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE) Research Committee (registration number ISSSTE\/CEI\/2013\/080) and by the Ethics and Research Committee of the Instituto Mexicano del Seguro Social (IMSS), CONBIOETICA-09-CEI-009-20160601 with the registration numbers R-2014-785-036 and R-2018-785-147.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"889"}}